Author:
Gregorchuk Branden S. J.,Reimer Shelby L.,Slipski Carmine J.,Milner Kieran A.,Hiebert Shannon L.,Beniac Daniel R.,Booth Timothy F.,Zhanel George G.,Bay Denice C.
Abstract
AbstractBacterial resistance to the antiseptic chlorhexidine (CHX), is a growing problem, recently shown to be caused by deleterious mutations to the phospholipid transport system component (mlaA) as well as efflux pump overexpression. Comparisons of CHX resistance mechanisms, such as porin deletions (ompCF), and over-expressed efflux pumps (acrB, qacE, aceI), are lacking and may be distinguishable using antiseptic rapid fluorescent dye testing assays. Using E. coli K-12 CHX adapted isolates (CHXR1), gene deletion mutants, and over-expressed transformants the phenotypes of these CHX resistance genes were compared using antimicrobial susceptibility tests (AST), rapid fluorescent propidium iodide dye-based membrane integrity assays (RFDMIA), and scanning electron microscopy (SEM). AST findings showed CHXR1, ΔacrB, ΔompCF, and transformants pCA24N-aceI and pCA24N-mlaA conferred greater (two to fourfold) MIC changes when compared to matched controls. Examination of these mutants/transformants using CHX RFDMIA showed that porin dual-deletions (ΔompCF) and mlaA alterations (ΔmlaA; pCA24N-mlaA, CHXR1) were distinguishable from controls. Results for over-expressed (pMS119EH-aceI) and deleted (ΔacrB) efflux pump RFDMIA could not be distinguished with propidium iodide, only with ethidium bromide, suggesting propidium iodide is better suited for detecting porin and mlaA associated CHX resistance mechanisms. SEM of CHXR1 and unadapted E. coli cells exposed to increasing CHX concentrations revealed that CHX does not visibly damage cell envelope integrity at any tested concentration but did identify elongated CHXR1 cells. ΔmlaA confers similar levels of CHX resistance as efflux overexpression and porin deletions, however, only outer membrane-altering porin and mlaA deletions can be reliably distinguished using RFDMIA.
Publisher
Springer Science and Business Media LLC
Reference57 articles.
1. Nayyar, A. S. Chlorhexidine: A cationic bisbiguanide, membrane active drug in periodontal medicine, structure advantages and associated adverse effects, a brief communication. World J. Pharm. Pharm. Sci. 4, 37–392 (2015).
2. Kane, S. P. ClinCalc.com: Chlorhexidine drug usage statistics, United States, 2008–2009. ClinCalc.com 1 https://clincalc.com/DrugStats/Drugs/Chlorhexidine (2021).
3. Zorko, M. & Jerala, R. Alexidine and chlorhexidine bind to lipopolysaccharide and lipoteichoic acid and prevent cell activation by antibiotics. J. Antimicrob. Chemother. 62, 730–737 (2008).
4. Gilbert, P. & Moore, L. E. Cationic antiseptics: Diversity of action under a common epithet. J. Appl. Microbiol. 99, 703–715 (2005).
5. Cieplik, F. et al. Resistance toward chlorhexidine in oral bacteria-is there cause for concern?. Front. Microbiol. 10, 587 (2019).
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献